Cessation of steroidogenesis in Leydig cell tumors after removal of luteinizing hormone and adenosine cyclic 3',5'-monophosphate.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D002247:Carbon Isotopes; D000242:Cyclic AMP / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D007106:Immune Sera; D066298:In Vitro Techniques; D007700:Kinetics; D007984:Leydig Cell Tumor / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000494:pharmacology*; D008660:Metabolism / Q000187:drug effects; D051379:Mice; D009374:Neoplasms, Experimental / Q000378:metabolism; D011374:Progesterone / Q000096:biosynthesis; D011388:Prolactin / Q000494:pharmacology; D014176:Protein Biosynthesis; D011955:Receptors, Drug; D013256:Steroids / Q000096:biosynthesis*; D013739:Testosterone / Q000096:biosynthesis
D000227:Adenine Nucleotides; D000596:Amino Acids; D002247:Carbon Isotopes; D007106:Immune Sera; D011955:Receptors, Drug; D013256:Steroids; D013739:Testosterone; D011374:Progesterone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D003513:Cycloheximide; D000242:Cyclic AMP